Business

Allied Corp has completed another sales transaction with a customer reorder. CanadianBusiness Journal

Kelowna, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Allied Corp.. (“Allied” or “Company”) (OTCQB: ALID) Announces the successful completion of another sale and shipment of a 10 kilogram CBD isolate from Colombia to Australia. This occurs as a reorder from a recurring sales contract that the Allies have entered into with an Australian partner.

The 10-kilogram order was divided into 100×100-gram bottles and then distributed by Allied partners to 100 pharmacies and medical institutions across Australia. Allied will continue to fulfill its contracts by completing regular sales cycles to multiple markets to which it ships.

“The team will continue to follow what it is trying to do. We will continue to produce high quality products, conclude sales contracts, manage logistics well and deliver to customers as committed. Every time a sales transaction is completed, we continue to consolidate our trade routes to multiple markets in the Allied Powers, which is to fulfill our existing purchase orders with our international partners. We look forward to shipping cannabis flowers, “said Calum Hughes, CEO and Chairman of Allied Corp.

About Allied Corp. – click here

Click here for the Allied Inside ™ Business Model website. click here

Allied Corp. is an international cannabis company with a major production center in Colombia and one of the few companies exporting internationally from Colombia. In preparation for the potential legalization of cannabis by the US federal government, the Allies also have the option of purchasing a US cannabis license that can be exercised in the United States (Nevada). In addition to this, Allied has three CBD brands for sale in products sold in the United States. Finally, Allied has both cannabinoid and psilocybin products on its drug development track in search of drug indications for depression, anxiety and PTSD.

Investor Public Relations:
ir@allied.health
1-877-255-4337

Forward-looking statement:
This press release contains “Forecast Information” (“Forecast Information”) in the sense of securities law applicable in Canada or the United States. Information about our future outlook may relate to our future outlook and expected events, plans, or results, and information about our objectives, goals, strategies, future earnings or performance and capital investment, and the past. It may contain other information that is not information about. Information about future prospects is often “believe”, “anticipate”, “plan”, “expect”, “pending”, “in progress”, “intended”, “estimate”, It can be identified using terms such as “project”. , ”,“ May ”,“ will ”,“ should ”,“ would ”,“ could ”,“ can ”, its negatives, its variations, and similar expressions. The forward-looking information contained in this press release includes our opinions, estimates and assumptions in the light of management’s experience and historical trends, current circumstances and perceptions of expected future developments, as well as management’s current. It is based on other factors that we consider appropriate. Reasonable depending on the situation. The forward-looking statements in this press release include: The Allies are supporting R & D efforts by leveraging the growth business of Colombia and the situation of future Kelowna locations. Allied has made significant progress in establishing its position as a leader in the medical cannabis field, and Allied has a set of trademarks and other knowledge as part of our Intellectual Property and Pharmaceutical Development (IP & PD) strategy. We are planning to apply for property protection. , TACTICAL RELIEF ™ branded product co-development, manufacturing and implementation statement.

There is no guarantee that the underlying opinions, estimates and assumptions will be proven to be correct. Risk factors that may cause actual results to differ materially from the forward-looking information for this release include: The impact of legalization of adult cannabis in Canada and Colombia on the medical cannabis industry is unknown and could have a significant and negative impact on our medical cannabis business. The medical benefits, feasibility, safety, efficacy, medication and social acceptance of cannabis are not currently expected. Unfavorable changes or developments that affect our key or planned facilities may adversely affect us. The medical cannabis industry and market may not exist or continue to develop as expected, or we may not be successful in this market. Risks related to the completion of greenhouse construction in Colombia, risks related to market competition. Risks associated with the adult cannabis industry and markets proposed in Canada and Colombia. This includes our ability to enter or compete in such markets. Our business history and net loss history are limited and we may not be able to achieve or maintain profitability in the future. Risks associated with our current or proposed international business. Risks associated with future strategic alliances with third parties or expanding current relationships with third parties. We may not be able to properly identify and execute future acquisitions or dispositions, or properly manage the impact of such transactions on our business. Risks inherent in running agribusiness. We may not be able to attract, train and retain key talent. Risks arising from a significant disruption of a company’s access to certain major inputs such as raw materials, electricity, water and other utilities. We may not be able to transport cannabis products to patients in a safe and efficient manner. Risks associated with recalls or product liability of our cannabis products, or regulatory claims or proceedings related to our cannabis products. Risks associated with dependence on our pharmaceutical companies. The company, or more generally the cannabis industry, may be adversely advertised or exposed to the negative perceptions of consumers or investors. Certain events or developments in the cannabis industry, more generally, can affect a company’s reputation or relationships with customers or suppliers. You may not be able to obtain adequate insurance for the risks we face, the premiums for such insurance may not be commercially justified, or the coverage may be limited and may lead to such insurance. There may be other exclusions. Not enough. The company may be subject to liability arising from fraudulent or illegal activity by employees, contractors, consultants, etc. We may experience facility security breaches or losses as a result of product theft. Risks associated with our information technology systems. We may not be able to sustain the growth and development of earnings. We may not be able to grow our business fast enough to meet demand or manage our business beyond its current scale. We may not be able to secure an appropriate or reliable source of funding for the required funding. Risks related to or related to our exposure to reporting requirements. Risks associated with conflicts of interest. Risks associated with fluctuations in exchange rates. Risks associated with our potential exposure to unexpected tax liabilities. Risks related to the protection and enforcement of our intellectual property rights or the intellectual property we license from others. You may be subject to allegations that we or our licensors infringe the intellectual property rights of third parties. It may not be possible to realize the full benefits of the clinical trials or studies in which we are participating. If the licensed material is less attractive to the market than expected and the license may not be profitable, we may not be able to realize the full profit of the license. It can also be further explained in our ongoing disclosure, including a section of management discussion and analysis of Form 10-Q quarterly report, Form 10-K annual report, and current report. Other Risks and Factors of Sex Form 8-K submitted under the company profile at www.sec.gov.

Management has sought to identify significant risk factors whose actual results may differ materially from those contained in the forward-looking information in this presentation, but are currently unknown to us or to us. There may be other risk factors that we are not currently considering. Also, materials that may cause actual results or future events may differ materially from those expressed in such forward-looking information in this presentation. Actual results and future events may differ materially from those expected from such information and there is no guarantee that such information will be proven to be accurate. Therefore, readers and viewers should not place undue reliance on forward-looking information that is only spoken as of the date it was created. The forward-looking information contained in this release represents our expectations as of the date of this release or the date indicated, regardless of the delivery time of the presentation. We disclaim any intentions, obligations, or promises to update or revise future outlook information as new information, future events, or other consequences, except as required by applicable securities law. ..


CBJ News Maker

Allied Corp has completed another sales transaction with a customer reorder. CanadianBusiness Journal

Source link Allied Corp has completed another sales transaction with a customer reorder. CanadianBusiness Journal

Related Articles

Back to top button